Citation Impact
52 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Julia Alcaide being referenced
Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC).
2021
The role and prognostic value of apoptosis in colorectal carcinoma
2013
Author Peers
| Author | Oncology | PFM | PRM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Julia Alcaide | 265 | 87 | 103 | 102 | 56 | 570 | |
| L. Blaikie | 3 | 15 | 5 | 11 | 508 | ||
| Suraj D. Umdale | 3 | 1 | 27 | 321 | |||
| Rajani Salunke | 4 | 8 | 2 | 12 | 11 | 322 | |
| Katerina I. Kalliampakou | 19 | 3 | 11 | 6 | 24 | 429 | |
| Kate Mortimer | 25 | 229 |
All Works
Login with ORCID to disown or claim papers
Loading papers...